ES2394200T8 - Procedimiento para la determinación de dosis de un antibiótico in vitro por medio de mecanismos de regulación genética y kit de diagnóstico correspondiente - Google Patents

Procedimiento para la determinación de dosis de un antibiótico in vitro por medio de mecanismos de regulación genética y kit de diagnóstico correspondiente Download PDF

Info

Publication number
ES2394200T8
ES2394200T8 ES02782543T ES02782543T ES2394200T8 ES 2394200 T8 ES2394200 T8 ES 2394200T8 ES 02782543 T ES02782543 T ES 02782543T ES 02782543 T ES02782543 T ES 02782543T ES 2394200 T8 ES2394200 T8 ES 2394200T8
Authority
ES
Spain
Prior art keywords
procedure
diagnostic kit
corresponding diagnostic
dose determination
regulation mechanisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES02782543T
Other languages
English (en)
Other versions
ES2394200T3 (es
Inventor
Benoît GRANIER
Sophie Lepage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisensor SA
Gesval SA
Original Assignee
Unisensor SA
Gesval SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisensor SA, Gesval SA filed Critical Unisensor SA
Application granted granted Critical
Publication of ES2394200T3 publication Critical patent/ES2394200T3/es
Publication of ES2394200T8 publication Critical patent/ES2394200T8/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES02782543T 2001-12-06 2002-12-04 Procedimiento para la determinación de dosis de un antibiótico in vitro por medio de mecanismos de regulación genética y kit de diagnóstico correspondiente Expired - Lifetime ES2394200T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01870273 2001-12-06
EP01870273A EP1318400A1 (fr) 2001-12-06 2001-12-06 Procédé pour effectuer un diagnostic in vitro au moyen de mécanismes de régulation génétique et trousse de diagnostic correspondante
PCT/BE2002/000183 WO2003048770A2 (fr) 2001-12-06 2002-12-04 Procede pour effectuer un diagnostic in vitro au moyen de mecanismes de regulation genetique et trousse de diagnostic correspondante

Publications (2)

Publication Number Publication Date
ES2394200T3 ES2394200T3 (es) 2013-01-23
ES2394200T8 true ES2394200T8 (es) 2013-02-25

Family

ID=8185066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02782543T Expired - Lifetime ES2394200T3 (es) 2001-12-06 2002-12-04 Procedimiento para la determinación de dosis de un antibiótico in vitro por medio de mecanismos de regulación genética y kit de diagnóstico correspondiente

Country Status (6)

Country Link
US (1) US7935806B2 (es)
EP (2) EP1318400A1 (es)
AU (1) AU2002347226A1 (es)
DK (1) DK1451583T3 (es)
ES (1) ES2394200T3 (es)
WO (1) WO2003048770A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712914A1 (fr) * 2005-04-14 2006-10-18 Unisensor S.A. Procédé in vitro pour la detection et l'identification simultanées d'antibiotiques de classes differentes et trousse de diagnostic correspondante
EP2058663A1 (en) * 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
CN102680711A (zh) * 2012-05-25 2012-09-19 北京维德维康生物技术有限公司 与四环素结合的蛋白TetR在检测四环素类抗生素中的应用
CN103808939A (zh) * 2012-11-06 2014-05-21 江苏维赛科技生物发展有限公司 大观霉素胶体金检测卡
CN103353525A (zh) * 2012-12-12 2013-10-16 河南省农业科学院 金霉素残留检测试纸条及试纸卡
CN113957067B (zh) * 2021-10-12 2023-11-07 中国农业大学 基于TetR蛋白空间位阻和基因剪切技术的四环素类药物检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217867A (en) * 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
US6133027A (en) * 1996-08-07 2000-10-17 City Of Hope Inducible expression system
US6025192A (en) * 1996-09-20 2000-02-15 Cold Spring Harbor Laboratory Modified retroviral vectors
US5854010A (en) * 1997-03-10 1998-12-29 Denison; Michael S. Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor

Also Published As

Publication number Publication date
EP1451583B1 (fr) 2012-08-29
US20050130152A1 (en) 2005-06-16
WO2003048770A3 (fr) 2004-04-01
DK1451583T3 (da) 2012-12-03
EP1451583A2 (fr) 2004-09-01
EP1318400A1 (fr) 2003-06-11
AU2002347226A8 (en) 2003-06-17
AU2002347226A1 (en) 2003-06-17
US7935806B2 (en) 2011-05-03
WO2003048770A2 (fr) 2003-06-12
ES2394200T3 (es) 2013-01-23

Similar Documents

Publication Publication Date Title
IL177876A0 (en) In vitro test system for predicting patient tolerability of therapeutic agents
DE602004031600D1 (de) Verschiebbares knochenplattensystem
FR2867962B1 (fr) Plaque d'osteosynthese et spherique
DE50312893D1 (de) Knochenplatte
ATE428362T1 (de) Knochenplatte
EP1682010A4 (en) SYSTEM FOR TISSUE CONFIGURATION AND FIXATION
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
NO20055011D0 (no) Tyngdepunkts romvippbar rullestol
PT1506781E (pt) Composicao para tratamento vaginal
ATE335722T1 (de) Benzoylsulfonamide und sulfonylbenzamidine zur verwendung als antitumor-mittel
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
EP1581119A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE
AU2002359989A1 (en) Splint combined use cast absence for bone fracture fixing
FR2852392B1 (fr) Composition de fixation tissulaire
AU2002362184A1 (en) Splint combined use cast absence for bone fracture fixing
DE10158785B8 (de) Medizinisches Implantat
HK1094150A1 (en) Thorium-227 for use in radiotherapy of soft tissue disease
RS51138B (sr) S-mirtazapin za lečenje nastupa vreline (valunga)
DE602004016877D1 (de) Untersuchungsstuhl
ES2394200T8 (es) Procedimiento para la determinación de dosis de un antibiótico in vitro por medio de mecanismos de regulación genética y kit de diagnóstico correspondiente
FR2845267B1 (fr) Kit cutane de diagnostic de l'atopie
GB2395342B (en) Compact medical emergency kit
AU2003224560A1 (en) Methods and arrangements for biological imaging
ES1054332Y (es) "perfil polivalente para la fijacion de laminas de metacrilato y similares"
ITRM20030219A1 (it) Uso della liquerizia per la prevenzione e la cura di aids e sars.